SNY vs. BMY
Compare and contrast key facts about Sanofi (SNY) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or BMY.
Correlation
The correlation between SNY and BMY is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. BMY - Performance Comparison
Key characteristics
SNY:
-0.07
BMY:
0.47
SNY:
0.06
BMY:
0.97
SNY:
1.01
BMY:
1.12
SNY:
-0.07
BMY:
0.28
SNY:
-0.18
BMY:
1.17
SNY:
8.86%
BMY:
11.55%
SNY:
22.20%
BMY:
28.54%
SNY:
-46.65%
BMY:
-70.62%
SNY:
-18.91%
BMY:
-24.50%
Fundamentals
SNY:
$122.70B
BMY:
$116.92B
SNY:
$1.89
BMY:
-$3.58
SNY:
0.76
BMY:
1.92
SNY:
$59.54B
BMY:
$47.44B
SNY:
$40.42B
BMY:
$33.40B
SNY:
$11.26B
BMY:
$5.06B
Returns By Period
In the year-to-date period, SNY achieves a -4.56% return, which is significantly lower than BMY's 15.27% return. Over the past 10 years, SNY has outperformed BMY with an annualized return of 3.87%, while BMY has yielded a comparatively lower 2.33% annualized return.
SNY
-4.56%
-1.13%
1.30%
-1.56%
1.77%
3.87%
BMY
15.27%
-3.31%
40.83%
16.07%
1.13%
2.33%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. BMY - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 4.29%, which matches BMY's 4.26% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 4.29% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% | 3.47% |
BMY Bristol-Myers Squibb Company | 4.26% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
SNY vs. BMY - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for SNY and BMY. For additional features, visit the drawdowns tool.
Volatility
SNY vs. BMY - Volatility Comparison
Sanofi (SNY) has a higher volatility of 8.69% compared to Bristol-Myers Squibb Company (BMY) at 5.85%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities